Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Omnicell (OMCL) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Omnicell (OMCL) over the last 16 years, with Q3 2025 value amounting to $5.5 million.

  • Omnicell's Net Income towards Common Stockholders fell 3670.92% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.9 million, marking a year-over-year increase of 21291.88%. This contributed to the annual value of $12.5 million for FY2024, which is 16151.39% up from last year.
  • As of Q3 2025, Omnicell's Net Income towards Common Stockholders stood at $5.5 million, which was down 3670.92% from $5.6 million recorded in Q2 2025.
  • Omnicell's Net Income towards Common Stockholders' 5-year high stood at $29.3 million during Q3 2021, with a 5-year trough of -$28.4 million in Q4 2022.
  • For the 5-year period, Omnicell's Net Income towards Common Stockholders averaged around $4.2 million, with its median value being $5.6 million (2025).
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 57508.72% in 2021, then tumbled by 30322.58% in 2022.
  • Omnicell's Net Income towards Common Stockholders (Quarter) stood at $14.0 million in 2021, then plummeted by 303.23% to -$28.4 million in 2022, then surged by 49.41% to -$14.4 million in 2023, then surged by 210.21% to $15.8 million in 2024, then tumbled by 65.52% to $5.5 million in 2025.
  • Its Net Income towards Common Stockholders stands at $5.5 million for Q3 2025, versus $5.6 million for Q2 2025 and -$7.0 million for Q1 2025.